The Role of Economics in the Health Sector

We all want to live long, healthy lives. We also want access to the best doctors, the most advanced technology, and the safest medicines. But there’s a fundamental problem: we can’t always have it all. A government has a limited budget. A hospital has a limited number of beds. A family has a limited income. This clash between our infinite desire for health and the finite resources available is where economics enters the picture. Economics isn’t just about money, stocks, and markets; at its core, it’s the study of scarcity. The health sector, perhaps more than any other, is defined by scarcity, and that makes economics one of its most critical, if sometimes controversial, partners.

Economics provides the toolkit for making these tough choices. It helps us analyze how to get the most “health” for our buck-a concept known as efficient allocation. It forces us to ask difficult questions: Should we spend millions on a cutting-edge cancer drug that extends 100 lives by six months, or should we use that same money to fund a vaccination program that saves 1,000 children? Economics doesn’t make the moral judgment, but it provides the framework for measuring the costs and consequences of either choice.

Applying economic principles to health 🔗

At first glance, it might feel strange to talk about “health” as a commodity, like a car or a loaf of bread. You can’t just go to a store and “buy” good health. Instead, you purchase healthcare services-a doctor’s appointment, a prescription, a surgery-that are inputs in the production of your own health. This distinction is crucial. You combine these medical inputs with your own “inputs,” like diet, exercise, and genetics, to produce a final outcome: your health status.

This “production” view of health is a cornerstone of health economics. It also highlights why health is such a special case. The World Health Organization (WHO) emphasizes that health economics addresses issues of efficiency, effectiveness, value, and behavior in the production and consumption of health. Unlike a simple market transaction, the “consumer” (the patient) rarely knows as much as the “seller” (the doctor), creating what economists call information asymmetry. Furthermore, the person paying (often an insurance company or the government) is frequently not the person consuming the service. These unique features make the health market prone to failure, requiring careful economic modeling and often, government intervention.

The core economic challenge remains resource allocation. Every decision has an opportunity cost. If a government decides to build a new high-tech hospital in a major city, the opportunity cost is everything else that money could have been spent on-perhaps 50 rural clinics, a nationwide nutrition program, or training for thousands of new nurses. Health economics provides tools like cost-benefit analysis (CBA) and cost-effectiveness analysis (CEA) to help policymakers compare these different options and (in theory) allocate their limited resources to achieve the maximum possible health gain for the population.

Neo-classical welfare economics in health 🔗

To understand the different ways to allocate resources, we first need to know the “traditional” or “mainstream” approach: neo-classical welfare economics. This framework, which dominated economic thought for much of the 20th century, has a very specific way of judging what makes a society “better off.” Its entire goal is to maximize overall “welfare,” which it defines as the sum of all individuals’ “utility” or happiness. This philosophy rests on four key pillars that have profound implications for healthcare.

1. Utility maximization 🔗

This is the idea that people are rational and will always make choices to maximize their own happiness or satisfaction (utility). In a perfect market, your choices reveal your preferences. If you choose to buy an apple instead of an orange, economists assume you must get more utility from the apple. In health, this means a patient, when fully informed, will choose the treatment, insurance plan, or lifestyle that gives them the most perceived benefit for the cost and risk involved.

2. Individual sovereignty 🔗

This is arguably the most important and most controversial tenet in healthcare. Individual sovereignty means you, the individual, are the best (and only) judge of your own welfare. The government or a doctor shouldn’t tell you what makes you happy. If a person chooses to smoke cigarettes, a strict neo-classical economist would argue that, as long as they know the risks, this choice must be maximizing their utility (perhaps the pleasure of smoking outweighs their perceived risk). Therefore, interfering with that choice would make them worse off. You can immediately see the problem this creates in public health, which is often based on the idea that some choices are objectively bad (like smoking) or good (like vaccinations).

3. Consequentialism 🔗

This principle states that we should judge the “goodness” of an action or policy only by its consequences. The process, intention, or fairness of how you get to the result doesn’t matter as much as the result itself. In neo-classical economics, the “result” we care about is the total utility. So, if a new health policy-let’s say, deregulating the pharmaceutical market-leads to a net increase in total societal utility (maybe drugs become cheaper for many, even if a few are harmed), a consequentialist would deem it a success.

4. Welfarism 🔗

Welfarism ties all the other tenets together. It’s the belief that the only thing we should care about when evaluating consequences is the utility (welfare) of individuals. According to welfarism, “health” itself has no independent value. Its only value comes from the *utility* it gives a person. This means a policy that improves the health of 1,000 people but slightly reduces the utility (perhaps through taxes) of 10,000 others could be seen as “bad.” This framework struggles with the concept of “need.” In welfarism, the “demand” of a wealthy person for cosmetic surgery (which gives them high utility) is just as valid as the “need” of a poor person for a life-saving antibiotic.

This approach faces deep challenges in health. It justifies allocating resources based on willingness to pay, not medical need. It struggles with public health measures like mandatory quarantines or vaccine mandates, which restrict individual sovereignty for the collective good. These shortcomings led many thinkers to seek an alternative.

Culver’s extra-welfarist approach 🔗

The dissatisfaction with welfarism gave rise to a powerful alternative known as the extra-welfarist approach. This framework, heavily influenced by the work of Nobel laureate Amartya Sen, builds on a simple but revolutionary idea: utility isn’t the only thing that matters. In fact, when it comes to the health sector, it might not even be the most important thing.

Building on Sen’s “capability approach”-which argues we should focus on what people are actually able to do and be (i.e., their capabilities), rather than just their happiness-economists like A. J. Culyer and Charles Culver argued for a new foundation. They proposed that the goal of the health sector is not to maximize “utility,” but to maximize “health.”

Health as the central outcome 🔗

This is the core shift. Extra-welfarism states that health has an intrinsic value, separate from the happiness it might bring. Being healthy is fundamentally good, and the objective of a health system should be to produce as much of it as possible, especially for those who have the least. This aligns much more closely with the values of medical professionals and the public, who instinctively believe a health ministry’s job is to improve *health*, not “happiness.” This approach allows us to value a year of life saved, regardless of whether that person is “happy” or “productive” in the traditional sense.

Integrating need and health, not demand and utility 🔗

Under this framework, the key concept for resource allocation is no longer demand (a want, backed by an ability to pay) but need. A “need” is defined as a capacity to benefit.

• A person “needs” a treatment if their health will significantly improve with it.
• A person does *not* “need” a treatment, even if they want it and can pay for it, if it offers no real health benefit.

This is a radical departure. It means that the poor person who cannot pay for a life-saving drug has a higher claim on resources than the wealthy person who wants a non-essential procedure. In India, for example, an extra-welfarist perspective would strongly support government intervention to cover the “missing middle”-those who are too rich for subsidized public schemes but too poor to afford private insurance-because their *need* for health coverage is high, even if their market “demand” is suppressed by cost.

This leads to an optimal solution that looks very different from the neo-classical one. Instead of funding services based on who pays the most, an extra-welfarist system funds services that produce the biggest health gain for the money, prioritizing those with the greatest need. This is the philosophical underpinning for public health services like the UK’s NHS and for government-funded schemes in many countries.

The efficiency wage hypothesis 🔗

So, must these two worlds-the “profit-and-utility” world of neo-classicism and the “health-and-need” world of extra-welfarism-always be in conflict? Not necessarily. The efficiency wage hypothesis provides a fascinating example of how an extra-welfarist concern (employee health) can actually serve a neo-classical goal (company profit).

The standard economic model says a company should pay its workers the lowest possible wage they will accept (the “market-clearing” wage). Anything more is wasted money. The efficiency wage hypothesis turns this on its head. As explained by economists like Janet Yellen and George Akerlof, it argues that paying employees *more* than the market rate can actually boost a firm’s profits.

Why paying more can increase profit 🔗

This theory suggests several reasons why a higher wage is “efficient”:

• Reduced Shirking: If an employee is paid well above the market rate, they have more to lose by being fired. They will work harder to avoid being caught slacking off.
• Lower Turnover: Higher pay reduces the incentive for employees to quit, saving the firm significant money on recruitment and training.
• Better Applicants: A high wage attracts a larger, more qualified pool of applicants, allowing the firm to hire the best.
• Improved Health and Nutrition: This is the key link. In many contexts, especially in developing countries or low-wage sectors, the market-clearing wage may be so low that employees cannot afford adequate nutrition or healthcare. They are more likely to be sick, weak, and unfocused. By paying an “efficiency wage,” a firm enables its workers to be healthier.

Health, fringe benefits, and the bottom line 🔗

This “health” channel, often discussed by economists like Paul Krugman in the context of development, is a powerful real-world example. A factory that pays its workers 20% above the local standard might find that its workforce is 30% more productive because they are better-fed, miss fewer days due to illness, and are more energetic. The productivity gain *more* than pays for the wage increase.

This provides a powerful justification for an extra-welfarist approach within a for-profit system. It’s the logic behind providing fringe benefits. When a company provides good health insurance, free healthy meals in the canteen, or an on-site gym, it is not just being “nice.” It is making a calculated investment. It is betting that the cost of these benefits will be more than offset by gains from reduced absenteeism (fewer sick days), reduced “presenteeism” (people showing up sick but not working effectively), and higher overall productivity. In this way, the efficiency wage hypothesis shows that investing in the *health* of employees-an extra-welfarist goal-can be one of the most profitable decisions a company can make.

What do you think? When your local or national government decides how to spend its health budget, do you think it leans more towards a “welfarist” approach (focusing on what people want) or an “extra-welfarist” approach (focusing on medical need)? And in your own life, do you see health more as a “consumption” good (something that makes you feel good) or an “investment” good (something that makes you more productive)?

References

1. https://www.who.int/news-room/questions-and-answers/item/health-economics
2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1089018/